- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- December 2024
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- January 2025
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 176 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 158 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- July 2025
- 190 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- November 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
From €6550EUR$7,500USD£5,690GBP
- Report
- May 2023
- 395 Pages
Global
From €3646EUR$4,175USD£3,167GBP
- Report
- December 2022
- 38 Pages
Global
From €3057EUR$3,500USD£2,655GBP
- Report
- June 2023
- 112 Pages
United States
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 114 Pages
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 129 Pages
Europe
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 119 Pages
Middle East, Africa
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 117 Pages
North America
From €3013EUR$3,450USD£2,617GBP
- Report
- November 2022
- 129 Pages
Asia Pacific
From €3013EUR$3,450USD£2,617GBP

The Helicobacter market is a subset of the Infectious Disease Testing market. It is focused on the detection and diagnosis of Helicobacter pylori, a type of bacteria that can cause stomach ulcers and other gastrointestinal issues. Diagnostic tests for Helicobacter pylori are used to detect the presence of the bacteria in the stomach, and to determine the best course of treatment. Tests may include stool antigen tests, urea breath tests, and serology tests.
The Helicobacter market is driven by the increasing prevalence of Helicobacter pylori infections, as well as the need for accurate and timely diagnosis and treatment. The market is expected to grow in the coming years, as new diagnostic technologies are developed and more people are diagnosed with the infection.
Some companies in the Helicobacter market include Abbott Laboratories, Becton Dickinson, Cepheid, DiaSorin, Hologic, and Roche Diagnostics. Show Less Read more